334 related articles for article (PubMed ID: 18810661)
1. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage.
Jang YG; Ilodigwe D; Macdonald RL
Neurocrit Care; 2009; 10(1):141-7. PubMed ID: 18810661
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
[TBL] [Abstract][Full Text] [Related]
4. Tirilazad for aneurysmal subarachnoid haemorrhage.
Zhang S; Wang L; Liu M; Wu B
Cochrane Database Syst Rev; 2010 Feb; (2):CD006778. PubMed ID: 20166088
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.
Lanzino G; Kassell NF
J Neurosurg; 1999 Jun; 90(6):1018-24. PubMed ID: 10350246
[TBL] [Abstract][Full Text] [Related]
6. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
[TBL] [Abstract][Full Text] [Related]
7. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage.
Ferguson S; Macdonald RL
Neurosurgery; 2007 Apr; 60(4):658-67; discussion 667. PubMed ID: 17415202
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage.
Macdonald RL; Rosengart A; Huo D; Karrison T
J Neurosurg; 2003 Oct; 99(4):644-52. PubMed ID: 14567598
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
Kassell NF; Haley EC; Apperson-Hansen C; Alves WM
J Neurosurg; 1996 Feb; 84(2):221-8. PubMed ID: 8592224
[TBL] [Abstract][Full Text] [Related]
10. Metaanalysis of trials of tirilazad mesylate in aneurysmal SAH.
Dorsch NW; Kassell NF; Sinkula MS
Acta Neurochir Suppl; 2001; 77():233-5. PubMed ID: 11563295
[No Abstract] [Full Text] [Related]
11. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
Haley EC; Kassell NF; Alves WM; Weir BK; Hansen CA
J Neurosurg; 1995 May; 82(5):786-90. PubMed ID: 7714603
[TBL] [Abstract][Full Text] [Related]
12. SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.
Macdonald RL; Jaja B; Cusimano MD; Etminan N; Hanggi D; Hasan D; Ilodigwe D; Lantigua H; Le Roux P; Lo B; Louffat-Olivares A; Mayer S; Molyneux A; Quinn A; Schweizer TA; Schenk T; Spears J; Todd M; Torner J; Vergouwen MD; Wong GK; Singh J;
Transl Stroke Res; 2013 Jun; 4(3):286-96. PubMed ID: 24323299
[TBL] [Abstract][Full Text] [Related]
13. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
[TBL] [Abstract][Full Text] [Related]
14. National socioeconomic indicators are associated with outcomes after aneurysmal subarachnoid hemorrhage: a hierarchical mixed-effects analysis.
Guha D; Ibrahim GM; Kertzer JD; Macdonald RL
J Neurosurg; 2014 Nov; 121(5):1039-47. PubMed ID: 25127417
[TBL] [Abstract][Full Text] [Related]
15. Effects of tirilazad mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage.
Suzuki H; Kanamaru K; Kuroki M; Sun H; Waga S; Miyazawa T
Stroke; 1999 Feb; 30(2):450-5; discussion 455-6. PubMed ID: 9933286
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Polin RS; Coenen VA; Hansen CA; Shin P; Baskaya MK; Nanda A; Kassell NF
J Neurosurg; 2000 Feb; 92(2):284-90. PubMed ID: 10659016
[TBL] [Abstract][Full Text] [Related]
17. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale.
Frontera JA; Claassen J; Schmidt JM; Wartenberg KE; Temes R; Connolly ES; MacDonald RL; Mayer SA
Neurosurgery; 2006 Jul; 59(1):21-7; discussion 21-7. PubMed ID: 16823296
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
Shen J; Pan JW; Fan ZX; Xiong XX; Zhan RY
J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
[TBL] [Abstract][Full Text] [Related]
19. [Indications for steroid and tirilazad treatment in patients with subarachnoid hemorrhage].
Tommasino C; Picozzi P
Minerva Anestesiol; 1998 May; 64(5):225-7. PubMed ID: 9773664
[TBL] [Abstract][Full Text] [Related]
20. Effect of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
Niu PP; Yang G; Xing YQ; Guo ZN; Yang Y
J Neurol Sci; 2014 Jan; 336(1-2):146-51. PubMed ID: 24211059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
